Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$3,232,464
+$1,519,853 QoQ
Shares Held
2,695
+44.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#2,060
of 4,605 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFW Advisors LLC holds $7,997,987 across 5 Drug Manufacturers - General names. LLY ranks #1 (40.4% of the industry book) .
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,232,464 | 2,695 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,712,611 | 1,862 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,987,083 | 1,849 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,467,249 | 1,923 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $658,702 | 845 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $706,153 | 855 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $662,376 | 858 | Shares | Sole | 2025-01-13 | |
| 2024-06-30 | $784,059 | 866 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $763,956 | 982 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $563,100 | 966 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $486,639 | 906 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $424,895 | 906 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||